Italian Drug Industry Drawn Into VortexOf Scandals

25 September 1994

Arrests of 18 drug industry managers and doctors in Sicily and others in several Italian cities have begun to have an impact on international drugmakers active in Italy. The managers and doctors are accused of selling diagnostic equipment and related reagents to the Italian health service at prices three to four times above normal.

Subsidiaries of German companies are said to be affected, but Bayer SpA in Milan has denied any involvement. Bayer says it will wait to see what evidence the State Prosecutor's office produces and will protect its interests through legal means. Two Bayer sales directors are among those arrested, as are four of Boehringer Mannheim's staff, directors of Beckman, Dasit and the civic hospital of Palermo.

Total Italian health service losses through the scandal are reported to have reached 1 billion lire ($639,000), in Sicily alone. The accountant for the Sicilian regional administration, Concetta Cimino, is said to have uncovered the racket, and as a result she has been under police protection for the past several months.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight